Compositions comprising theanine, s-adenosylmethionine (SAMe), and/or
An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of Magnolia , an extract of Phellodendron , and a whey protein.
1. An anxiolytic composition, comprising a synergistic combination of L-theanine and s-adenosylmethionine (SAMe) at a ratio of about 1.1:1, wherein the synergistic combination provides an anxiolytic change in a release pattern of one or more neurotransmitters.
2. The anxiolytic composition of claim 1 , wherein the neurotransmitters are brain neurotransmitters selected from the group consisting of glutamate and γ-aminobutyric acid (GABA).
3. The anxiolytic composition of claim 1 , formulated for oral administration to a mammal.
4. The anxiolytic composition of claim 1 , wherein the s-adenosylmethionine (SAMe) comprises a SAMe phytate salt.
5. The anxiolytic composition of claim 1 , further comprising an extract of magnolia and an extract of phellodendron.
6. An anxiolytic composition, comprising a synergistic combination of L-theanine in an amount of at least 2.0 mg and s-adenosylmethionine (SAMe) in an amount of at least 1.0 mg, wherein the synergistic combination provides an anxiolytic change in a release pattern of one or more neurotransmitters.
7. The anxiolytic composition of claim 6 , wherein the neurotransmitters are brain neurotransmitters selected from the group consisting of glutamate and γ-aminobutyric acid (GABA).
8. The anxiolytic composition of claim 6 , formulated for oral administration to a mammal.
9. The anxiolytic composition of claim 6 , wherein the s-adenosylmethionine (SAMe) comprises a SAMe phytate salt.
10. The anxiolytic composition of claim 6 , further comprising an extract of magnolia and an extract of phellodendron.